NCT01901185View on ClinicalTrials.gov

Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept

PHASE3CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

June 11, 2013

Primary Completion Date

December 18, 2013

Study Completion Date

December 30, 2013

Conditions
Rheumatoid ArthritisPsoriatic Arthritis
Interventions
DRUG

Etanercept / Autoinjector A

Autoinjector A, a hand-held, reusable electromechanical device, and a single-use, disposable cassette preassembled with an etanercept 50-mg liquid prefilled syringe (PFS).

Trial Locations (13)

14127

Research Site, Orchard Park

16635

Research Site, Duncansville

33614

Research Site, Tampa

34239

Research Site, Sarasota

35801

Research Site, Huntsville

42003

Research Site, Paducah

68516

Research Site, Lincoln

73103

Research Site, Oklahoma City

80230

Research Site, Denver

85037

Research Site, Phoenix

85381

Research Site, Peoria

91786

Research Site, Upland

93454-6945

Research Site, Santa Maria

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT01901185 - Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept | Biotech Hunter | Biotech Hunter